Camptothecin (Compound)

Synonyms:camptothecin, Camptothecine, 7689-03-4, (S)-(+)-Camptothecin, Campathecin, (+)-Camptothecine, d-Camptothecin, (+)-Camptothecin, 20(S)-Camptothecine, 21,22-Secocamptothecin-21-oic acid lactone, NSC94600, Camptothecine (S,+), CHEMBL65, NSC-94600, (S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, MLS000766223, XT3Z54Z28A, CHEBI:27656, MFCD00081076, (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione, NSC 100880, (S)-Camptothecin, (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-, 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-, 20(S)-Camptothecin, 4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE, SR-01000075798, SR-01000597379, d-camptothecine, (s)-camptothecine, Camptothecin,(S), ( )-Camptothecin, (4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, (S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, (S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, Prestwick_102, (+)-Camptothecin;, Camptothecine (8CI), Spectrum_000299, Tocris-1100, SpecPlus_000712, Prestwick0_000200, Prestwick1_000200, Prestwick2_000200, Prestwick3_000200, Spectrum2_000903, Spectrum3_001203, Spectrum4_000738, Spectrum5_001126, CAMPTOTHECIN [MI], Lopac-C-9911, SCHEMBL6038, UNII-XT3Z54Z28A, Lopac0_000341, BSPBio_000159, BSPBio_002586, KBioGR_001036, KBioSS_000779, KBioSS_002283, cid_24360, CAMPTOTHECIN [WHO-DD], DivK1c_000826, DivK1c_006808, SPECTRUM1502232, SPBio_000746, SPBio_002080, BPBio1_000175, CCRIS 8162, DTXSID0030956, HMS502J08, KBio1_000826, KBio1_001752, KBio2_000779, KBio2_003347, KBio2_005915, KBio3_002086, 4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, NINDS_000826, Bio1_000400, Bio1_000889, Bio1_001378, HMS1568H21, HMS1921N08, HMS2089F08, HMS2095H21, HMS3261E03, HMS3414J17, HMS3654D13, HMS3678J15, HMS3712H21, ACT02668, BCP02857, Tox21_500341, AC-202, BBL033963, BDBM50008923, CCG-40255, GR-301, NSC 94600, s1288, STK801886, AKOS004119861, CS-1049, DB04690, KS-5235, LP00341, SDCCGMLS-0066688.P001, SDCCGSBI-0050329.P003, BRN 0631069, CAS-2114454, IDI1_000826, NCGC00015290-01, NCGC00016994-01, NCGC00016994-02, NCGC00016994-03, NCGC00016994-04, NCGC00016994-05, NCGC00016994-06, NCGC00016994-07, NCGC00016994-08, NCGC00016994-09, NCGC00016994-10, NCGC00016994-11, NCGC00016994-12, NCGC00016994-16, NCGC00016994-29, NCGC00024997-01, NCGC00024997-02, NCGC00024997-03, NCGC00024997-04, NCGC00024997-05, NCGC00024997-06, NCGC00178592-01, NCGC00178592-02, NCGC00261026-01, HY-16560, NCI60_042105, SMR000445686, SY010324, AI3-62475, EU-0100341, SW196414-3, C 9911, C01897, M01564, AB00052452-08, AB00052452-09, AB00052452_10, EN300-1725804, (S)-(+)-Camptothecin, >=90% (HPLC), powder, A838882, Q419964, Q-200785, SR-01000075798-1, SR-01000075798-4, SR-01000597379-1, SR-01000597379-3, BRD-K37890730-001-09-4, BRD-K37890730-001-10-2, Z1741982070, (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]florene-3,13-dione, (S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione, 4-Ethyl-4-hydroxy-1H-pyrano-[3[,4[:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione, (S)-4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, (S)-4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(S)-(+)-Camptothecin, (S)-4-Ethyl-4-hydroxy-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione, 1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-, 4(S)-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione, 4-ethyl-4-hydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione, 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (camptothecin or CPT), 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Camptothecin), 4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (CPT, Camptothecin)
Pubchem:PUBCHEM:24360
Id:595196f6-05fc-5fe2-954d-43477832fb82
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Camptothecin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Camptothecin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Camptothecin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.